FDMT
4D Molecular Therapeutics Inc
14.70$
-1.9%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | -338.6% | – | – | |
| – | +8.4% | +5.4% | +1.9% | +4.9% | +4.8% | -1.7% | +7.6% | +6.1% | -1.1% | +3.8% | -76.0% | – | |
| – | +29.6% | +1.0% | +1.7% | +6.9% | +16.8% | -7.8% | -29.0% | -8.9% | +22.9% | -19.8% | +32.1% | – | |
| – | -78.6% | -630.1% | – | – | -143.9% | – | – | -10.6% | -44.9% | -272.5% | – | – | |
| – | +35.6% | +29.3% | -50.8% | +409.5% | -46.6% | -33.5% | -89.5% | +37.9% | +593.4% | -100.0% | – | – | |
| – | -122.3% | +3,839.8% | -72.1% | – | -74.1% | +352.6% | -143.4% | – | -824.8% | – | -62.9% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -54.9% | +6,595.3% | -94.6% | -96.7% | +5.8% | -100.0% | – | -86.5% | +96,436.2% | -89.7% | +268.7% | – | |
| – | -167.5% | – | -426.7% | – | – | – | – | – | – | +4.8% | -117.3% | – | |
| – | – | – | – | – | – | – | – | – | – | -344.0% | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.